$21.56
+0.69 (+3.31%)
Analyst Consensus
Strong Buy
18
Analysts
High
Coverage
Price Target
Analyst Price Target
+31.0% upside
Low Target
$22.54
Average Target
$28.24
High Target
$42.65
Current Price
$21.56
Current
$21.56
$21.56
Target
$28.24
$28.24
$22.54
$28.24 avg
$42.65
Scenario Analysis
Bear Case
$22.54
4.5%
Low target
Base Case
$28.24
+31.0%
Avg target
Bull Case
$42.65
+97.8%
High target
Risk/Reward
21.5x
Highly favorable
Price in Context
52-Week High
$34.39
-37.3% from high
52-Week Low
$7.37
+192.5% from low
Target vs 52W High
$28.24
-17.9% vs high
Next Earnings Report
Nov 10, 2026
2d
until earnings
EPS Est: $-0.36
Earnings in 2 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 82% | $257.58 | -11.6% |
| AMGN | Hold | 42 | 43% | $190.87 | -58.5% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +117.3% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -19.9% |
| MRNA | Hold | 31 | 35% | $149.45 | -41.2% |
| REGN | Buy | 37 | 70% | $76.80 | -91.5% |
| NTRA | Strong Buy | 30 | 90% | $142.91 | -54.0% |
| RVMD | Strong Buy | 29 | 93% | $114.11 | -40.7% |